Bausch Health to Announce Third Quarter 2025 Results on October 29
Rhea-AI Summary
Bausch Health (NYSE:BHC) has scheduled its third quarter 2025 financial results announcement for October 29, 2025, after market close. The company will host a conference call and webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update.
All presentation materials will be available on the company's Investor Relations website before the call begins. A replay of the conference call will also be accessible through the investor relations website at ir.bauschhealth.com.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, BHC declined 0.31%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
LAVAL, QC / ACCESS Newswire / September 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2025 financial results after market close on Wednesday, October 29, 2025. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: | Wednesday, October 29, 2025 |
Time: | 5:00 p.m. U.S. EDT |
Webcast: |
A replay of the conference call will be available on the investor relations website.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
###
Investor Contact: | Media Contact: | |
Garen Sarafian | Katie Savastano | |
(877) 281-6642 (toll-free) | (908) 541-3785 |
SOURCE: Bausch Health Companies Inc.
View the original press release on ACCESS Newswire
FAQ
When will Bausch Health (BHC) release Q3 2025 earnings?
What time is the Bausch Health Q3 2025 earnings call?
How can I access Bausch Health's Q3 2025 earnings call?
Will there be a replay available of Bausch Health's Q3 earnings call?
